| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $443.6M | +17.7% |
| Cost of Revenue | $86.3M | +31.8% |
| Gross Profit | $357.3M | +14.8% |
| R&D Expense | $97.2M | +21.3% |
| SG&A Expense | $106.4M | +35.3% |
| Operating Income | -$22.8M | -374.6% |
| Pre-tax Income | -$10.1M | -149.5% |
| Income Tax | $9.4M | -27.9% |
| Net Income | -$19.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $264.3M | +440.7% |
| Accounts Receivable | $26.5M | +195.8% |
| Current Assets | $324.8M | +17.6% |
| Total Assets | $454.1M | +16.2% |
| Current Liabilities | $154.1M | +35.0% |
| Total Liabilities | $163.1M | +30.9% |
| Stockholders' Equity | $288.6M | +12.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $59.6M | +26.8% |
| Capital Expenditures | $1.8M | -52.8% |
| Investing Cash Flow | $162.9M | +379.9% |
| Financing Cash Flow | -$7.5M | -502.9% |
| Free Cash Flow | $57.8M | +33.8% |
| -330.2% |
| EPS (Basic) | -$0.13 | -316.7% |
| EPS (Diluted) | -$0.13 | -316.7% |